110 related articles for article (PubMed ID: 7495543)
41. Directed evolution of beta-galactosidase from Escherichia coli into beta-glucuronidase.
Xiong AS; Peng RH; Zhuang J; Liu JG; Xu F; Cai B; Guo ZK; Qiao YS; Chen JM; Zhang Z; Yao QH
J Biochem Mol Biol; 2007 May; 40(3):419-25. PubMed ID: 17562294
[TBL] [Abstract][Full Text] [Related]
42. A dominant selectable marker for the construction of recombinant poxviruses.
Boyle DB; Coupar BE
Gene; 1988 May; 65(1):123-8. PubMed ID: 2840353
[TBL] [Abstract][Full Text] [Related]
43. Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus.
Scheiflinger F; Dorner F; Falkner FG
Arch Virol; 1998; 143(3):467-74. PubMed ID: 9572548
[TBL] [Abstract][Full Text] [Related]
44. Vaccinia virus as a vector.
Beaud G; Mars M; Vassef A
Dev Biol Stand; 1987; 66():49-54. PubMed ID: 3582771
[No Abstract] [Full Text] [Related]
45. Construction and application of plasmids containing bidirectional promoters of vaccinia virus.
Tsao H; Liu GQ; Ruan L; Chu CM
J Virol; 1988 Dec; 62(12):4832-4. PubMed ID: 2846896
[TBL] [Abstract][Full Text] [Related]
46. A recombinant vaccinia virus infects Xenopus melanophores.
Potenza MN; Lerner MR
Pigment Cell Res; 1991 Oct; 4(4):186-92. PubMed ID: 1816550
[TBL] [Abstract][Full Text] [Related]
47. Efficient and rapid procedure for blue-white screening of recombinant bacterial clones.
Maas S
Biotechniques; 1999 Dec; 27(6):1126-8. PubMed ID: 10631489
[No Abstract] [Full Text] [Related]
48. Simultaneous detection of different Rhizobium strains marked with either the Escherichia coli gusA gene or the Pyrococcus furiosus celB gene.
Sessitsch A; Wilson KJ; Akkermans AD; de Vos WM
Appl Environ Microbiol; 1996 Nov; 62(11):4191-4. PubMed ID: 8900009
[TBL] [Abstract][Full Text] [Related]
49. A comparison of directed evolution approaches using the beta-glucuronidase model system.
Rowe LA; Geddie ML; Alexander OB; Matsumura I
J Mol Biol; 2003 Sep; 332(4):851-60. PubMed ID: 12972256
[TBL] [Abstract][Full Text] [Related]
50. The use of the Escherichia coli beta-glucuronidase as a gene fusion marker for studies of gene expression in higher plants.
Jefferson RA; Bevan M; Kavanagh T
Biochem Soc Trans; 1987 Feb; 15(1):17-8. PubMed ID: 3549385
[No Abstract] [Full Text] [Related]
51. Effects of compartment size on the kinetics of intracompartmental multimeric protein synthesis.
Matsuura T; Hosoda K; Kazuta Y; Ichihashi N; Suzuki H; Yomo T
ACS Synth Biol; 2012 Sep; 1(9):431-7. PubMed ID: 23651340
[TBL] [Abstract][Full Text] [Related]
52. Release of genetically altered viruses into the environment.
Bishop DH
Br Med J (Clin Res Ed); 1988 Jun; 296(6638):1685-6. PubMed ID: 3135876
[No Abstract] [Full Text] [Related]
53. Use of polymerase chain reaction for detecting DNA contaminants in pharmaceutical recombinant products.
Goldman M; Geier M; Zehnder D; Wang A; Henriksson T
Clin Chem; 1991 Sep; 37(9):1523-5. PubMed ID: 1893582
[No Abstract] [Full Text] [Related]
54. Paraffin wax as a vapor barrier for the PCR.
Sparkman DR
PCR Methods Appl; 1992 Nov; 2(2):180-1. PubMed ID: 1477675
[No Abstract] [Full Text] [Related]
55. Studies on beta-glucuronidase from E. coli.
BUEHLER HJ; KATZMAN PA; DOISY EA
Proc Soc Exp Biol Med; 1951 Apr; 76(4):672-6. PubMed ID: 14844308
[No Abstract] [Full Text] [Related]
56. Characterization of an African Swine Fever Virus Field Isolate from Vietnam with Deletions in the Left Variable Multigene Family Region.
Ambagala A; Goonewardene K; Kanoa IE; Than TT; Nguyen VT; Lai TNH; Nguyen TL; Erdelyan CNG; Robert E; Tailor N; Onyilagha C; Lamboo L; Handel K; Nebroski M; Vernygora O; Lung O; Le VP
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675912
[TBL] [Abstract][Full Text] [Related]
57. The Envelope-Based Fusion Antigen GP120C14K Forming Hexamer-Like Structures Triggers T Cell and Neutralizing Antibody Responses Against HIV-1.
Raman SC; Mejías-Pérez E; Gomez CE; García-Arriaza J; Perdiguero B; Vijayan A; Pérez-Ruiz M; Cuervo A; Santiago C; Sorzano COS; Sánchez-Corzo C; Moog C; Burger JA; Schorcht A; Sanders RW; Carrascosa JL; Esteban M
Front Immunol; 2019; 10():2793. PubMed ID: 31867001
[TBL] [Abstract][Full Text] [Related]
58. Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus.
Guo ZS; Liu Z; Sathaiah M; Wang J; Ravindranathan R; Kim E; Huang S; Kenniston TW; Bell JC; Zeh HJ; Butterfield LH; Gambotto A; Bartlett DL
Mol Ther Methods Clin Dev; 2017 Dec; 7():112-122. PubMed ID: 29085848
[TBL] [Abstract][Full Text] [Related]
59. Generation of Recombinant Vaccinia Viruses.
Wyatt LS; Earl PL; Moss B
Curr Protoc Protein Sci; 2017 Aug; 89():5.13.1-5.13.18. PubMed ID: 28762491
[TBL] [Abstract][Full Text] [Related]
60. Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.
Volz A; Sutter G
Adv Virus Res; 2017; 97():187-243. PubMed ID: 28057259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
